Global Apheresis Market, By Product, By Procedure, By Technology, By Application, By End-User, By Region & Segmental Insights Trends and Forecast, 2024 – 2034

  • Industry: Healthcare
  • Report ID: TNR-110-1115
  • Number of Pages: 420
  • Table/Charts : Yes
  • June, 2024
  • Base Year : 2024
  • No. of Companies : 10+
  • No. of Countries : 29
  • Views : 10026
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Apheresis is a medical procedure that involves removing specific components from a patient’s blood and returning the remaining blood components to the patient’s circulation. The process utilizes a specialized machine called an apheresis machine or apheresis device, which separates blood into its individual components, such as red blood cells, white blood cells, platelets, plasma, or specific blood proteins.

Plasmapheresis involves removing plasma from the patient’s blood, which contains antibodies, proteins, and other soluble factors. This procedure is commonly used to treat autoimmune disorders, neurological diseases, and certain hematological conditions by removing harmful antibodies or toxins from the bloodstream. Apheresis procedures contribute to the supply of blood products, including plasma, platelets, and red blood cells, which are essential for various medical treatments and transfusion therapies. As the demand for blood products increases due to factors such as population growth, aging demographics, and advances in medical care, there is a corresponding need for apheresis procedures to collect and process these products. Apheresis centers play a critical role in maintaining adequate supplies of blood components to meet patient needs and support healthcare delivery. In terms of revenue, the global apheresis market was worth US$ 2.48 Bn in 2023, anticipated to witness CAGR of 8.2% during 2024 – 2034.

Trends in the Global Apheresis Market

  • Increasing Demand for Therapeutic Apheresis: There is a growing demand for therapeutic apheresis procedures to treat a wide range of medical conditions, including autoimmune diseases, hematologic disorders, neurological disorders, and solid organ transplant complications. Therapeutic apheresis is increasingly recognized as an effective treatment modality for removing pathogenic substances, disease-causing factors, or aberrant cells from the bloodstream, offering targeted therapeutic interventions with favorable outcomes for patients.
  • Rising Incidence of Chronic Diseases: The increasing prevalence of chronic diseases such as autoimmune disorders, hematologic malignancies, renal diseases, and neurological disorders is driving the demand for apheresis procedures globally. As the burden of chronic diseases continues to rise due to factors such as aging populations, lifestyle changes, and environmental factors, there is a corresponding need for advanced therapies like apheresis to manage disease symptoms, improve patient outcomes, and enhance quality of life.
  • Growing Focus on Regenerative Medicine: Apheresis plays a crucial role in regenerative medicine applications, particularly in stem cell collection and processing for hematopoietic stem cell transplantation (HSCT) and cell-based therapies. The growing interest in regenerative medicine and cell-based therapies for treating various diseases and injuries has spurred demand for apheresis procedures to obtain high-quality stem cells, immune cells, or progenitor cells for therapeutic purposes. Apheresis centers are increasingly recognized as key players in supporting regenerative medicine initiatives and advancing cell-based therapies.

Global Apheresis Market Revenue & Forecast, (US$ Million), 2016 – 2034

Apheresis device has garnered major market share in the global apheresis market during the forecast period.  An apheresis device is a medical instrument designed to perform apheresis, a therapeutic procedure that involves the separation and extraction of specific components from a patient’s blood. These devices are sophisticated machines equipped with various components and mechanisms to facilitate the safe and efficient removal or collection of blood components. Apheresis devices are equipped with ports or catheters that allow access to the patient’s bloodstream. These ports are typically connected to the patient’s veins through venous catheters or vascular access devices, providing a means for withdrawing blood from the body and returning processed blood components. The growing prevalence of chronic conditions such as autoimmune diseases, hematologic disorders, and neurological diseases drives the demand for apheresis procedures. Conditions like multiple sclerosis, myasthenia gravis, and thrombotic thrombocytopenic purpura often require apheresis to remove harmful antibodies, abnormal blood cells, or disease-causing factors from the bloodstream, leading to increased demand for apheresis devices.

Plasmapheresis application had the highest share in the global apheresis market in 2023.

Plasmapheresis is widely used in the treatment of autoimmune disorders, including Guillain-Barré syndrome, myasthenia gravis, systemic lupus erythematosus (SLE), and autoimmune hemolytic anemia. In these conditions, the immune system produces antibodies that attack healthy tissues or cells, leading to inflammation and tissue damage. Plasmapheresis helps remove circulating antibodies and immune complexes from the bloodstream, reducing disease severity and improving patient outcomes. Plasmapheresis is effective in managing various neurological conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), multiple sclerosis (MS), and neuromyelitis optica spectrum disorder (NMOSD). By removing pathogenic antibodies and inflammatory mediators from the bloodstream, plasmapheresis helps reduce inflammation, prevent nerve damage, and alleviate neurological symptoms, leading to improved quality of life for patients.

By end user blood collection centers and blood component providers segment had the highest share in the global apheresis market in 2023.

The demand for blood and blood components is closely tied to the number of medical procedures and surgeries performed. Surgical interventions, trauma care, cancer treatments, organ transplants, and childbirth are some of the medical situations that may require blood transfusions or blood products. As the population grows and ages, the demand for medical procedures increases, driving the need for blood collection centers to supply adequate blood products. Through the collection, processing, and distribution of blood products to meet the needs of patients undergoing various medical treatments, surgeries, and transfusions, blood collection centers and blood component providers play a crucial role in the healthcare ecosystem. These facilities need cutting-edge apheresis technologies to effectively collect and separate blood components from whole blood donations as the demand for blood components like plasma, platelets, and red blood cells continuously growing.

By region North America dominated the global apheresis market in 2023.

North America is at the forefront of technological innovation in apheresis procedures. Apheresis procedures are integral to the field of transplantation and immunotherapy in North America. Apheresis is used to collect hematopoietic stem cells for autologous and allogeneic stem cell transplantation, as well as to remove donor-specific antibodies or pathogenic immune cells in the context of solid organ transplantation and hematopoietic stem cell transplantation (HSCT). Apheresis plays a crucial role in mitigating transplant-related complications, promoting graft acceptance, and improving long-term transplant outcomes. The demand for apheresis procedures in North America is driven by the need to effectively manage autoimmune, neurological, hematologic, and transplant-related disorders, as well as the availability of clinical guidelines, advancements in apheresis technology, and evidence-based practice recommendations. As healthcare providers recognize the clinical benefits of apheresis and patients seek alternative treatment options for complex medical conditions, the demand for apheresis procedures is expected to continue to grow in North America.

Competitive Landscape

Some of the players operating in the apheresis market are

  • Asahi Kasei Medical Co. Ltd.
  • Baxter International
  • Cerus Corporation
  • Fresenius Medical Care
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kaneka Corporation
  • Kawasumi Laboratories Inc.
  • Macopharma SA
  • Nikkiso Co.Ltd.
  • Otsuka Holdings Co. Ltd
  • Terumo BCT Inc.
  • Other Industry Participants

Global Apheresis Market Scope

Report Specifications Details
Market Revenue in 2023 US$ 2.48 Bn
Market Size Forecast by 2034 US$ 5.90 Bn
Growth Rate (CAGR) 8.2%
Historic Data 2016 – 2022
Base Year for Estimation 2023
Forecast Period 2024 – 2034
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Product, By Procedure, By Technology, By Application, By End-User, By Region
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Asahi Kasei Medical Co. Ltd., Baxter International, Cerus Corporation, Fresenius Medical Care, Haemonetics Corporation, HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Macopharma SA, Nikkiso Co.Ltd., Otsuka Holdings Co. Ltd, Terumo BCT Inc.
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

 Global Apheresis Market

By Product

  • Apheresis disposables
  • Apheresis devices
    • Centrifugal apheresis devices
    • Membrane separators

By Procedure

  • Automated blood collection
  • Therapeutic apheresis
    • Therapeutic apheresis disposables
      • Neurological disorders
      • Blood disorders
      • Renal disorders
      • Autoimmune disorders
      • Metabolic disorders
      • Cardiovascular disorders
      • Other disorders
    • Therapeutic apheresis devices

By Technology

  • Centrifugation
    • Continuous flow centrifugation
    • Intermittent flow centrifugation
  • Membrane separation

By Application

  • Plasmapheresis
  • plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Photopheresis
  • Other applications

By End User

  • Blood collection centers and blood component providers
  • Hospitals and transfusion centers
  • Other end users

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

 Report Layout

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2016 – 2022
1.2.2.Base Year: 2023
1.2.3.Forecast Years: 2024 – 2034
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of Apheresis Market
6.Market Synopsis: Apheresis Market
7.Apheresis Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Apheresis Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Apheresis Market
7.6.Industry Gross Margin Overview
7.7.Porter’s Five Force Analysis
7.8.Impact of Covid-19 on Apheresis Market
7.9.PESTEL Analysis
7.10.Value Chain Analysis
7.11.Pricing Analysis, By Region (2019 and 2020)
7.11.1.North America
7.11.2.Europe
7.11.3.Asia Pacific
7.11.4.Middle East and Africa
7.11.5.Latin America
8.Global Apheresis Market Analysis and Forecasts, 2024 – 2034
8.1.Overview
8.1.1.Global Apheresis Market Revenue (US$ Mn)
8.2.Global Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
8.2.1.Apheresis disposables
8.2.1.1.Definition
8.2.1.2.Market Estimation and Penetration, 2016 – 2023
8.2.1.3.Market Forecast, 2024 – 2034
8.2.1.4.Compound Annual Growth Rate (CAGR)
8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2016 – 2023
8.2.1.5.1.2.Market Forecast, 2024 – 2034
8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2016 – 2023
8.2.1.5.2.2.Market Forecast, 2024 – 2034
8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2016 – 2023
8.2.1.5.3.2.Market Forecast, 2024 – 2034
8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2016 – 2023
8.2.1.5.4.2.Market Forecast, 2024 – 2034
8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2016 – 2023
8.2.1.5.5.2.Market Forecast, 2024 – 2034
8.2.2.Apheresis devices (Definition, Market Estimation and Penetration, 2016 – 2023, Market Estimation (2016 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Centrifugal apheresis devices, Membrane separators)
8.2.2.1.Centrifugal apheresis devices
8.2.2.2.Membrane separators
8.3.Key Segment for Channeling Investments
8.3.1.By Product
9.Global Apheresis Market Analysis and Forecasts, 2024 – 2034
9.1.Overview
9.2.Global Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
9.2.1.Automated blood collection
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2016 – 2023
9.2.1.3.Market Forecast, 2024 – 2034
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2016 – 2023
9.2.1.5.1.2.Market Forecast, 2024 – 2034
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2016 – 2023
9.2.1.5.2.2.Market Forecast, 2024 – 2034
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2016 – 2023
9.2.1.5.3.2.Market Forecast, 2024 – 2034
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2016 – 2023
9.2.1.5.4.2.Market Forecast, 2024 – 2034
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2016 – 2023
9.2.1.5.5.2.Market Forecast, 2024 – 2034
9.2.2.Therapeutic apheresis (Definition, Market Estimation and Penetration, 2016 – 2023, Market Estimation (2016 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Therapeutic apheresis disposables, Therapeutic apheresis devices)
9.2.2.1.Therapeutic apheresis disposables
9.2.2.1.1.Neurological disorders
9.2.2.1.2.Blood disorders
9.2.2.1.3.Renal disorders
9.2.2.1.4.Autoimmune disorders
9.2.2.1.5.Metabolic disorders
9.2.2.1.6.Cardiovascular disorders
9.2.2.1.7.Other disorders
9.2.2.2.Therapeutic apheresis devices
9.3.Key Segment for Channeling Investments
9.3.1.By Procedure
10.Global Apheresis Market Analysis and Forecasts, 2024 – 2034
10.1.Overview
10.2.Global Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
10.2.1.Centrifugation (Definition, Market Estimation and Penetration, 2016 – 2023, Market Estimation (2016 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Continuous flow centrifugation, Intermittent flow centrifugation)
10.2.1.1.Continuous flow centrifugation
10.2.1.2.Intermittent flow centrifugation
10.2.2.Membrane separation
10.2.2.1.Definition
10.2.2.2.Market Estimation and Penetration, 2016 – 2023
10.2.2.3.Market Forecast, 2024 – 2034
10.2.2.4.Compound Annual Growth Rate (CAGR)
10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2016 – 2023
10.2.2.5.1.2.Market Forecast, 2024 – 2034
10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2016 – 2023
10.2.2.5.2.2.Market Forecast, 2024 – 2034
10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2016 – 2023
10.2.2.5.3.2.Market Forecast, 2024 – 2034
10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2016 – 2023
10.2.2.5.4.2.Market Forecast, 2024 – 2034
10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2016 – 2023
10.2.2.5.5.2.Market Forecast, 2024 – 2034
10.3.Key Segment for Channeling Investments
10.3.1.By Technology
11.Global Apheresis Market Analysis and Forecasts, 2024 – 2034
11.1.Overview
11.2.Global Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
11.2.1.Plasmapheresis
11.2.1.1.Definition
11.2.1.2.Market Estimation and Penetration, 2016 – 2023
11.2.1.3.Market Forecast, 2024 – 2034
11.2.1.4.Compound Annual Growth Rate (CAGR)
11.2.1.5.Regional Bifurcation
11.2.1.5.1.North America
11.2.1.5.1.1.Market Estimation, 2016 – 2023
11.2.1.5.1.2.Market Forecast, 2024 – 2034
11.2.1.5.2.Europe
11.2.1.5.2.1.Market Estimation, 2016 – 2023
11.2.1.5.2.2.Market Forecast, 2024 – 2034
11.2.1.5.3.Asia Pacific
11.2.1.5.3.1.Market Estimation, 2016 – 2023
11.2.1.5.3.2.Market Forecast, 2024 – 2034
11.2.1.5.4.Middle East and Africa
11.2.1.5.4.1.Market Estimation, 2016 – 2023
11.2.1.5.4.2.Market Forecast, 2024 – 2034
11.2.1.5.5.Latin America
11.2.1.5.5.1.Market Estimation, 2016 – 2023
11.2.1.5.5.2.Market Forecast, 2024 – 2034
11.2.2.Plateletpheresis
11.2.2.1.Definition
11.2.2.2.Market Estimation and Penetration, 2016 – 2023
11.2.2.3.Market Forecast, 2024 – 2034
11.2.2.4.Compound Annual Growth Rate (CAGR)
11.2.2.5.Regional Bifurcation
11.2.2.5.1.North America
11.2.2.5.1.1.Market Estimation, 2016 – 2023
11.2.2.5.1.2.Market Forecast, 2024 – 2034
11.2.2.5.2.Europe
11.2.2.5.2.1.Market Estimation, 2016 – 2023
11.2.2.5.2.2.Market Forecast, 2024 – 2034
11.2.2.5.3.Asia Pacific
11.2.2.5.3.1.Market Estimation, 2016 – 2023
11.2.2.5.3.2.Market Forecast, 2024 – 2034
11.2.2.5.4.Middle East and Africa
11.2.2.5.4.1.Market Estimation, 2016 – 2023
11.2.2.5.4.2.Market Forecast, 2024 – 2034
11.2.2.5.5.Latin America
11.2.2.5.5.1.Market Estimation, 2016 – 2023
11.2.2.5.5.2.Market Forecast, 2024 – 2034
11.2.3.Erythrocytapheresis
11.2.3.1.Definition
11.2.3.2.Market Estimation and Penetration, 2016 – 2023
11.2.3.3.Market Forecast, 2024 – 2034
11.2.3.4.Compound Annual Growth Rate (CAGR)
11.2.3.5.Regional Bifurcation
11.2.3.5.1.North America
11.2.3.5.1.1.Market Estimation, 2016 – 2023
11.2.3.5.1.2.Market Forecast, 2024 – 2034
11.2.3.5.2.Europe
11.2.3.5.2.1.Market Estimation, 2016 – 2023
11.2.3.5.2.2.Market Forecast, 2024 – 2034
11.2.3.5.3.Asia Pacific
11.2.3.5.3.1.Market Estimation, 2016 – 2023
11.2.3.5.3.2.Market Forecast, 2024 – 2034
11.2.3.5.4.Middle East and Africa
11.2.3.5.4.1.Market Estimation, 2016 – 2023
11.2.3.5.4.2.Market Forecast, 2024 – 2034
11.2.3.5.5.Latin America
11.2.3.5.5.1.Market Estimation, 2016 – 2023
11.2.3.5.5.2.Market Forecast, 2024 – 2034
11.2.4.Leukapheresis
11.2.4.1.Definition
11.2.4.2.Market Estimation and Penetration, 2016 – 2023
11.2.4.3.Market Forecast, 2024 – 2034
11.2.4.4.Compound Annual Growth Rate (CAGR)
11.2.4.5.Regional Bifurcation
11.2.4.5.1.North America
11.2.4.5.1.1.Market Estimation, 2016 – 2023
11.2.4.5.1.2.Market Forecast, 2024 – 2034
11.2.4.5.2.Europe
11.2.4.5.2.1.Market Estimation, 2016 – 2023
11.2.4.5.2.2.Market Forecast, 2024 – 2034
11.2.4.5.3.Asia Pacific
11.2.4.5.3.1.Market Estimation, 2016 – 2023
11.2.4.5.3.2.Market Forecast, 2024 – 2034
11.2.4.5.4.Middle East and Africa
11.2.4.5.4.1.Market Estimation, 2016 – 2023
11.2.4.5.4.2.Market Forecast, 2024 – 2034
11.2.4.5.5.Latin America
11.2.4.5.5.1.Market Estimation, 2016 – 2023
11.2.4.5.5.2.Market Forecast, 2024 – 2034
11.2.5.Photopheresis
11.2.5.1.Definition
11.2.5.2.Market Estimation and Penetration, 2016 – 2023
11.2.5.3.Market Forecast, 2024 – 2034
11.2.5.4.Compound Annual Growth Rate (CAGR)
11.2.5.5.Regional Bifurcation
11.2.5.5.1.North America
11.2.5.5.1.1.Market Estimation, 2016 – 2023
11.2.5.5.1.2.Market Forecast, 2024 – 2034
11.2.5.5.2.Europe
11.2.5.5.2.1.Market Estimation, 2016 – 2023
11.2.5.5.2.2.Market Forecast, 2024 – 2034
11.2.5.5.3.Asia Pacific
11.2.5.5.3.1.Market Estimation, 2016 – 2023
11.2.5.5.3.2.Market Forecast, 2024 – 2034
11.2.5.5.4.Middle East and Africa
11.2.5.5.4.1.Market Estimation, 2016 – 2023
11.2.5.5.4.2.Market Forecast, 2024 – 2034
11.2.5.5.5.Latin America
11.2.5.5.5.1.Market Estimation, 2016 – 2023
11.2.5.5.5.2.Market Forecast, 2024 – 2034
11.2.6.Other applications
11.2.6.1.Definition
11.2.6.2.Market Estimation and Penetration, 2016 – 2023
11.2.6.3.Market Forecast, 2024 – 2034
11.2.6.4.Compound Annual Growth Rate (CAGR)
11.2.6.5.Regional Bifurcation
11.2.6.5.1.North America
11.2.6.5.1.1.Market Estimation, 2016 – 2023
11.2.6.5.1.2.Market Forecast, 2024 – 2034
11.2.6.5.2.Europe
11.2.6.5.2.1.Market Estimation, 2016 – 2023
11.2.6.5.2.2.Market Forecast, 2024 – 2034
11.2.6.5.3.Asia Pacific
11.2.6.5.3.1.Market Estimation, 2016 – 2023
11.2.6.5.3.2.Market Forecast, 2024 – 2034
11.2.6.5.4.Middle East and Africa
11.2.6.5.4.1.Market Estimation, 2016 – 2023
11.2.6.5.4.2.Market Forecast, 2024 – 2034
11.2.6.5.5.Latin America
11.2.6.5.5.1.Market Estimation, 2016 – 2023
11.2.6.5.5.2.Market Forecast, 2024 – 2034
11.3.Key Segment for Channeling Investments
11.3.1.By Application
12.Global Apheresis Market Analysis and Forecasts, 2024 – 2034
12.1.Overview
12.2.Global Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
12.2.1.Blood collection centers and blood component providers
12.2.1.1.Definition
12.2.1.2.Market Estimation and Penetration, 2016 – 2023
12.2.1.3.Market Forecast, 2024 – 2034
12.2.1.4.Compound Annual Growth Rate (CAGR)
12.2.1.5.Regional Bifurcation
12.2.1.5.1.North America
12.2.1.5.1.1.Market Estimation, 2016 – 2023
12.2.1.5.1.2.Market Forecast, 2024 – 2034
12.2.1.5.2.Europe
12.2.1.5.2.1.Market Estimation, 2016 – 2023
12.2.1.5.2.2.Market Forecast, 2024 – 2034
12.2.1.5.3.Asia Pacific
12.2.1.5.3.1.Market Estimation, 2016 – 2023
12.2.1.5.3.2.Market Forecast, 2024 – 2034
12.2.1.5.4.Middle East and Africa
12.2.1.5.4.1.Market Estimation, 2016 – 2023
12.2.1.5.4.2.Market Forecast, 2024 – 2034
12.2.1.5.5.Latin America
12.2.1.5.5.1.Market Estimation, 2016 – 2023
12.2.1.5.5.2.Market Forecast, 2024 – 2034
12.2.2.Hospitals and transfusion centers
12.2.2.1.Definition
12.2.2.2.Market Estimation and Penetration, 2016 – 2023
12.2.2.3.Market Forecast, 2024 – 2034
12.2.2.4.Compound Annual Growth Rate (CAGR)
12.2.2.5.Regional Bifurcation
12.2.2.5.1.North America
12.2.2.5.1.1.Market Estimation, 2016 – 2023
12.2.2.5.1.2.Market Forecast, 2024 – 2034
12.2.2.5.2.Europe
12.2.2.5.2.1.Market Estimation, 2016 – 2023
12.2.2.5.2.2.Market Forecast, 2024 – 2034
12.2.2.5.3.Asia Pacific
12.2.2.5.3.1.Market Estimation, 2016 – 2023
12.2.2.5.3.2.Market Forecast, 2024 – 2034
12.2.2.5.4.Middle East and Africa
12.2.2.5.4.1.Market Estimation, 2016 – 2023
12.2.2.5.4.2.Market Forecast, 2024 – 2034
12.2.2.5.5.Latin America
12.2.2.5.5.1.Market Estimation, 2016 – 2023
12.2.2.5.5.2.Market Forecast, 2024 – 2034
12.2.3.Other end users
12.2.3.1.Definition
12.2.3.2.Market Estimation and Penetration, 2016 – 2023
12.2.3.3.Market Forecast, 2024 – 2034
12.2.3.4.Compound Annual Growth Rate (CAGR)
12.2.3.5.Regional Bifurcation
12.2.3.5.1.North America
12.2.3.5.1.1.Market Estimation, 2016 – 2023
12.2.3.5.1.2.Market Forecast, 2024 – 2034
12.2.3.5.2.Europe
12.2.3.5.2.1.Market Estimation, 2016 – 2023
12.2.3.5.2.2.Market Forecast, 2024 – 2034
12.2.3.5.3.Asia Pacific
12.2.3.5.3.1.Market Estimation, 2016 – 2023
12.2.3.5.3.2.Market Forecast, 2024 – 2034
12.2.3.5.4.Middle East and Africa
12.2.3.5.4.1.Market Estimation, 2016 – 2023
12.2.3.5.4.2.Market Forecast, 2024 – 2034
12.2.3.5.5.Latin America
12.2.3.5.5.1.Market Estimation, 2016 – 2023
12.2.3.5.5.2.Market Forecast, 2024 – 2034
12.3.Key Segment for Channeling Investments
12.3.1.By End User
13.North America Apheresis Market Analysis and Forecasts, 2024 – 2034
13.1.Overview
13.1.1.North America Apheresis Market Revenue (US$ Mn)
13.2.North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
13.2.1.Apheresis disposables
13.2.2.Apheresis devices
13.2.2.1.Centrifugal apheresis devices
13.2.2.2.Membrane separators
13.3.North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
13.3.1.Automated blood collection
13.3.2.Therapeutic apheresis
13.3.2.1.Therapeutic apheresis disposables
13.3.2.1.1.Neurological disorders
13.3.2.1.2.Blood disorders
13.3.2.1.3.Renal disorders
13.3.2.1.4.Autoimmune disorders
13.3.2.1.5.Metabolic disorders
13.3.2.1.6.Cardiovascular disorders
13.3.2.1.7.Other disorders
13.3.2.2.Therapeutic apheresis devices
13.4.North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
13.4.1.Centrifugation
13.4.1.1.Continuous flow centrifugation
13.4.1.2.Intermittent flow centrifugation
13.4.2.Membrane separation
13.5.North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.Plasmapheresis
13.5.2.Plateletpheresis
13.5.3.Erythrocytapheresis
13.5.4.Leukapheresis
13.5.5.Photopheresis
13.5.6.Other applications
13.6.North America Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
13.6.1.Blood collection centers and blood component providers
13.6.2.Hospitals and transfusion centers
13.6.3.Other end users
13.7.North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1.U.S
13.7.1.1.U.S Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
13.7.1.1.1.Apheresis disposables
13.7.1.1.2.Apheresis devices
13.7.1.1.2.1.Centrifugal apheresis devices
13.7.1.1.2.2.Membrane separators
13.7.1.2.U.S Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
13.7.1.2.1.Automated blood collection
13.7.1.2.2.Therapeutic apheresis
13.7.1.2.2.1.Therapeutic apheresis disposables
13.7.1.2.2.1.1.Neurological disorders
13.7.1.2.2.1.2.Blood disorders
13.7.1.2.2.1.3.Renal disorders
13.7.1.2.2.1.4.Autoimmune disorders
13.7.1.2.2.1.5.Metabolic disorders
13.7.1.2.2.1.6.Cardiovascular disorders
13.7.1.2.2.1.7.Other disorders
13.7.1.2.2.2.Therapeutic apheresis devices
13.7.1.3.U.S Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.1.3.1.Centrifugation
13.7.1.3.1.1.Continuous flow centrifugation
13.7.1.3.1.2.Intermittent flow centrifugation
13.7.1.3.2.Membrane separation
13.7.1.4.U.S Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.4.1.Plasmapheresis
13.7.1.4.2.Plateletpheresis
13.7.1.4.3.Erythrocytapheresis
13.7.1.4.4.Leukapheresis
13.7.1.4.5.Photopheresis
13.7.1.4.6.Other applications
13.7.1.5.U.S Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
13.7.1.5.1.Blood collection centers and blood component providers
13.7.1.5.2.Hospitals and transfusion centers
13.7.1.5.3.Other end users
13.7.2.Canada
13.7.2.1.Canada Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
13.7.2.1.1.Apheresis disposables
13.7.2.1.2.Apheresis devices
13.7.2.1.2.1.Centrifugal apheresis devices
13.7.2.1.2.2.Membrane separators
13.7.2.2.Canada Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
13.7.2.2.1.Automated blood collection
13.7.2.2.2.Therapeutic apheresis
13.7.2.2.2.1.Therapeutic apheresis disposables
13.7.2.2.2.1.1.Neurological disorders
13.7.2.2.2.1.2.Blood disorders
13.7.2.2.2.1.3.Renal disorders
13.7.2.2.2.1.4.Autoimmune disorders
13.7.2.2.2.1.5.Metabolic disorders
13.7.2.2.2.1.6.Cardiovascular disorders
13.7.2.2.2.1.7.Other disorders
13.7.2.2.2.2.Therapeutic apheresis devices
13.7.2.3.Canada Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.2.3.1.Centrifugation
13.7.2.3.1.1.Continuous flow centrifugation
13.7.2.3.1.2.Intermittent flow centrifugation
13.7.2.3.2.Membrane separation
13.7.2.4.Canada Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.4.1.Plasmapheresis
13.7.2.4.2.Plateletpheresis
13.7.2.4.3.Erythrocytapheresis
13.7.2.4.4.Leukapheresis
13.7.2.4.5.Photopheresis
13.7.2.4.6.Other applications
13.7.2.5.Canada Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
13.7.2.5.1.Blood collection centers and blood component providers
13.7.2.5.2.Hospitals and transfusion centers
13.7.2.5.3.Other end users
13.7.3.Mexico
13.7.3.1.Mexico Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
13.7.3.1.1.Apheresis disposables
13.7.3.1.2.Apheresis devices
13.7.3.1.2.1.Centrifugal apheresis devices
13.7.3.1.2.2.Membrane separators
13.7.3.2.Mexico Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
13.7.3.2.1.Automated blood collection
13.7.3.2.2.Therapeutic apheresis
13.7.3.2.2.1.Therapeutic apheresis disposables
13.7.3.2.2.1.1.Neurological disorders
13.7.3.2.2.1.2.Blood disorders
13.7.3.2.2.1.3.Renal disorders
13.7.3.2.2.1.4.Autoimmune disorders
13.7.3.2.2.1.5.Metabolic disorders
13.7.3.2.2.1.6.Cardiovascular disorders
13.7.3.2.2.1.7.Other disorders
13.7.3.2.2.2.Therapeutic apheresis devices
13.7.3.3.Mexico Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.3.3.1.Centrifugation
13.7.3.3.1.1.Continuous flow centrifugation
13.7.3.3.1.2.Intermittent flow centrifugation
13.7.3.3.2.Membrane separation
13.7.3.4.Mexico Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.4.1.Plasmapheresis
13.7.3.4.2.Plateletpheresis
13.7.3.4.3.Erythrocytapheresis
13.7.3.4.4.Leukapheresis
13.7.3.4.5.Photopheresis
13.7.3.4.6.Other applications
13.7.3.5.Mexico Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
13.7.3.5.1.Blood collection centers and blood component providers
13.7.3.5.2.Hospitals and transfusion centers
13.7.3.5.3.Other end users
13.7.4.Rest of North America
13.7.4.1.Rest of North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
13.7.4.1.1.Apheresis disposables
13.7.4.1.2.Apheresis devices
13.7.4.1.2.1.Centrifugal apheresis devices
13.7.4.1.2.2.Membrane separators
13.7.4.2.Rest of North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
13.7.4.2.1.Automated blood collection
13.7.4.2.2.Therapeutic apheresis
13.7.4.2.2.1.Therapeutic apheresis disposables
13.7.4.2.2.1.1.Neurological disorders
13.7.4.2.2.1.2.Blood disorders
13.7.4.2.2.1.3.Renal disorders
13.7.4.2.2.1.4.Autoimmune disorders
13.7.4.2.2.1.5.Metabolic disorders
13.7.4.2.2.1.6.Cardiovascular disorders
13.7.4.2.2.1.7.Other disorders
13.7.4.2.2.2.Therapeutic apheresis devices
13.7.4.3.Rest of North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.4.3.1.Centrifugation
13.7.4.3.1.1.Continuous flow centrifugation
13.7.4.3.1.2.Intermittent flow centrifugation
13.7.4.3.2.Membrane separation
13.7.4.4.Rest of North America Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.4.4.1.Plasmapheresis
13.7.4.4.2.Plateletpheresis
13.7.4.4.3.Erythrocytapheresis
13.7.4.4.4.Leukapheresis
13.7.4.4.5.Photopheresis
13.7.4.4.6.Other applications
13.7.4.5.Rest of North America Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
13.7.4.5.1.Blood collection centers and blood component providers
13.7.4.5.2.Hospitals and transfusion centers
13.7.4.5.3.Other end users
13.8.Key Segment for Channeling Investments
13.8.1.By Country
13.8.2.By Product
13.8.3.By Procedure
13.8.4.By Technology
13.8.5.By Application
13.8.6.By End User
14.Europe Apheresis Market Analysis and Forecasts, 2024 – 2034
14.1.Overview
14.1.1.Europe Apheresis Market Revenue (US$ Mn)
14.2.Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.2.1.Apheresis disposables
14.2.2.Apheresis devices
14.2.2.1.Centrifugal apheresis devices
14.2.2.2.Membrane separators
14.3.Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.3.1.Automated blood collection
14.3.2.Therapeutic apheresis
14.3.2.1.Therapeutic apheresis disposables
14.3.2.1.1.Neurological disorders
14.3.2.1.2.Blood disorders
14.3.2.1.3.Renal disorders
14.3.2.1.4.Autoimmune disorders
14.3.2.1.5.Metabolic disorders
14.3.2.1.6.Cardiovascular disorders
14.3.2.1.7.Other disorders
14.3.2.2.Therapeutic apheresis devices
14.4.Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.4.1.Centrifugation
14.4.1.1.Continuous flow centrifugation
14.4.1.2.Intermittent flow centrifugation
14.4.2.Membrane separation
14.5.Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.Plasmapheresis
14.5.2.Plateletpheresis
14.5.3.Erythrocytapheresis
14.5.4.Leukapheresis
14.5.5.Photopheresis
14.5.6.Other applications
14.6.Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.6.1.Blood collection centers and blood component providers
14.6.2.Hospitals and transfusion centers
14.6.3.Other end users
14.7.Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1.France
14.7.1.1.France Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.1.1.1.Apheresis disposables
14.7.1.1.2.Apheresis devices
14.7.1.1.2.1.Centrifugal apheresis devices
14.7.1.1.2.2.Membrane separators
14.7.1.2.France Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.1.2.1.Automated blood collection
14.7.1.2.2.Therapeutic apheresis
14.7.1.2.2.1.Therapeutic apheresis disposables
14.7.1.2.2.1.1.Neurological disorders
14.7.1.2.2.1.2.Blood disorders
14.7.1.2.2.1.3.Renal disorders
14.7.1.2.2.1.4.Autoimmune disorders
14.7.1.2.2.1.5.Metabolic disorders
14.7.1.2.2.1.6.Cardiovascular disorders
14.7.1.2.2.1.7.Other disorders
14.7.1.2.2.2.Therapeutic apheresis devices
14.7.1.3.France Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.1.3.1.Centrifugation
14.7.1.3.1.1.Continuous flow centrifugation
14.7.1.3.1.2.Intermittent flow centrifugation
14.7.1.3.2.Membrane separation
14.7.1.4.France Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.4.1.Plasmapheresis
14.7.1.4.2.Plateletpheresis
14.7.1.4.3.Erythrocytapheresis
14.7.1.4.4.Leukapheresis
14.7.1.4.5.Photopheresis
14.7.1.4.6.Other applications
14.7.1.5.France Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.1.5.1.Blood collection centers and blood component providers
14.7.1.5.2.Hospitals and transfusion centers
14.7.1.5.3.Other end users
14.7.2.The UK
14.7.2.1.The UK Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.2.1.1.Apheresis disposables
14.7.2.1.2.Apheresis devices
14.7.2.1.2.1.Centrifugal apheresis devices
14.7.2.1.2.2.Membrane separators
14.7.2.2.The UK Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.2.2.1.Automated blood collection
14.7.2.2.2.Therapeutic apheresis
14.7.2.2.2.1.Therapeutic apheresis disposables
14.7.2.2.2.1.1.Neurological disorders
14.7.2.2.2.1.2.Blood disorders
14.7.2.2.2.1.3.Renal disorders
14.7.2.2.2.1.4.Autoimmune disorders
14.7.2.2.2.1.5.Metabolic disorders
14.7.2.2.2.1.6.Cardiovascular disorders
14.7.2.2.2.1.7.Other disorders
14.7.2.2.2.2.Therapeutic apheresis devices
14.7.2.3.The UK Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.2.3.1.Centrifugation
14.7.2.3.1.1.Continuous flow centrifugation
14.7.2.3.1.2.Intermittent flow centrifugation
14.7.2.3.2.Membrane separation
14.7.2.4.The UK Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.4.1.Plasmapheresis
14.7.2.4.2.Plateletpheresis
14.7.2.4.3.Erythrocytapheresis
14.7.2.4.4.Leukapheresis
14.7.2.4.5.Photopheresis
14.7.2.4.6.Other applications
14.7.2.5.The UK Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.2.5.1.Blood collection centers and blood component providers
14.7.2.5.2.Hospitals and transfusion centers
14.7.2.5.3.Other end users
14.7.3.Spain
14.7.3.1.Spain Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.3.1.1.Apheresis disposables
14.7.3.1.2.Apheresis devices
14.7.3.1.2.1.Centrifugal apheresis devices
14.7.3.1.2.2.Membrane separators
14.7.3.2.Spain Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.3.2.1.Automated blood collection
14.7.3.2.2.Therapeutic apheresis
14.7.3.2.2.1.Therapeutic apheresis disposables
14.7.3.2.2.1.1.Neurological disorders
14.7.3.2.2.1.2.Blood disorders
14.7.3.2.2.1.3.Renal disorders
14.7.3.2.2.1.4.Autoimmune disorders
14.7.3.2.2.1.5.Metabolic disorders
14.7.3.2.2.1.6.Cardiovascular disorders
14.7.3.2.2.1.7.Other disorders
14.7.3.2.2.2.Therapeutic apheresis devices
14.7.3.3.Spain Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.3.3.1.Centrifugation
14.7.3.3.1.1.Continuous flow centrifugation
14.7.3.3.1.2.Intermittent flow centrifugation
14.7.3.3.2.Membrane separation
14.7.3.4.Spain Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.4.1.Plasmapheresis
14.7.3.4.2.Plateletpheresis
14.7.3.4.3.Erythrocytapheresis
14.7.3.4.4.Leukapheresis
14.7.3.4.5.Photopheresis
14.7.3.4.6.Other applications
14.7.3.5.Spain Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.3.5.1.Blood collection centers and blood component providers
14.7.3.5.2.Hospitals and transfusion centers
14.7.3.5.3.Other end users
14.7.4.Germany
14.7.4.1.Germany Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.4.1.1.Apheresis disposables
14.7.4.1.2.Apheresis devices
14.7.4.1.2.1.Centrifugal apheresis devices
14.7.4.1.2.2.Membrane separators
14.7.4.2.Germany Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.4.2.1.Automated blood collection
14.7.4.2.2.Therapeutic apheresis
14.7.4.2.2.1.Therapeutic apheresis disposables
14.7.4.2.2.1.1.Neurological disorders
14.7.4.2.2.1.2.Blood disorders
14.7.4.2.2.1.3.Renal disorders
14.7.4.2.2.1.4.Autoimmune disorders
14.7.4.2.2.1.5.Metabolic disorders
14.7.4.2.2.1.6.Cardiovascular disorders
14.7.4.2.2.1.7.Other disorders
14.7.4.2.2.2.Therapeutic apheresis devices
14.7.4.3.Germany Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.4.3.1.Centrifugation
14.7.4.3.1.1.Continuous flow centrifugation
14.7.4.3.1.2.Intermittent flow centrifugation
14.7.4.3.2.Membrane separation
14.7.4.4.Germany Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.4.1.Plasmapheresis
14.7.4.4.2.Plateletpheresis
14.7.4.4.3.Erythrocytapheresis
14.7.4.4.4.Leukapheresis
14.7.4.4.5.Photopheresis
14.7.4.4.6.Other applications
14.7.4.5.Germany Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.4.5.1.Blood collection centers and blood component providers
14.7.4.5.2.Hospitals and transfusion centers
14.7.4.5.3.Other end users
14.7.5.Italy
14.7.5.1.Italy Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.5.1.1.Apheresis disposables
14.7.5.1.2.Apheresis devices
14.7.5.1.2.1.Centrifugal apheresis devices
14.7.5.1.2.2.Membrane separators
14.7.5.2.Italy Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.5.2.1.Automated blood collection
14.7.5.2.2.Therapeutic apheresis
14.7.5.2.2.1.Therapeutic apheresis disposables
14.7.5.2.2.1.1.Neurological disorders
14.7.5.2.2.1.2.Blood disorders
14.7.5.2.2.1.3.Renal disorders
14.7.5.2.2.1.4.Autoimmune disorders
14.7.5.2.2.1.5.Metabolic disorders
14.7.5.2.2.1.6.Cardiovascular disorders
14.7.5.2.2.1.7.Other disorders
14.7.5.2.2.2.Therapeutic apheresis devices
14.7.5.3.Italy Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.5.3.1.Centrifugation
14.7.5.3.1.1.Continuous flow centrifugation
14.7.5.3.1.2.Intermittent flow centrifugation
14.7.5.3.2.Membrane separation
14.7.5.4.Italy Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.4.1.Plasmapheresis
14.7.5.4.2.Plateletpheresis
14.7.5.4.3.Erythrocytapheresis
14.7.5.4.4.Leukapheresis
14.7.5.4.5.Photopheresis
14.7.5.4.6.Other applications
14.7.5.5.Italy Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.5.5.1.Blood collection centers and blood component providers
14.7.5.5.2.Hospitals and transfusion centers
14.7.5.5.3.Other end users
14.7.6.Nordic Countries
14.7.6.1.Nordic Countries Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.6.1.1.Apheresis disposables
14.7.6.1.2.Apheresis devices
14.7.6.1.2.1.Centrifugal apheresis devices
14.7.6.1.2.2.Membrane separators
14.7.6.2.Nordic Countries Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.6.2.1.Automated blood collection
14.7.6.2.2.Therapeutic apheresis
14.7.6.2.2.1.Therapeutic apheresis disposables
14.7.6.2.2.1.1.Neurological disorders
14.7.6.2.2.1.2.Blood disorders
14.7.6.2.2.1.3.Renal disorders
14.7.6.2.2.1.4.Autoimmune disorders
14.7.6.2.2.1.5.Metabolic disorders
14.7.6.2.2.1.6.Cardiovascular disorders
14.7.6.2.2.1.7.Other disorders
14.7.6.2.2.2.Therapeutic apheresis devices
14.7.6.3.Nordic Countries Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.6.3.1.Centrifugation
14.7.6.3.1.1.Continuous flow centrifugation
14.7.6.3.1.2.Intermittent flow centrifugation
14.7.6.3.2.Membrane separation
14.7.6.4.Nordic Countries Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.6.4.1.Plasmapheresis
14.7.6.4.2.Plateletpheresis
14.7.6.4.3.Erythrocytapheresis
14.7.6.4.4.Leukapheresis
14.7.6.4.5.Photopheresis
14.7.6.4.6.Other applications
14.7.6.5.Nordic Countries Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.6.5.1.Blood collection centers and blood component providers
14.7.6.5.2.Hospitals and transfusion centers
14.7.6.5.3.Other end users
14.7.6.6.Nordic Countries Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1.Denmark
14.7.6.6.2.Finland
14.7.6.6.3.Iceland
14.7.6.6.4.Sweden
14.7.6.6.5.Norway
14.7.7.Benelux Union
14.7.7.1.Benelux Union Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.7.1.1.Apheresis disposables
14.7.7.1.2.Apheresis devices
14.7.7.1.2.1.Centrifugal apheresis devices
14.7.7.1.2.2.Membrane separators
14.7.7.2.Benelux Union Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.7.2.1.Automated blood collection
14.7.7.2.2.Therapeutic apheresis
14.7.7.2.2.1.Therapeutic apheresis disposables
14.7.7.2.2.1.1.Neurological disorders
14.7.7.2.2.1.2.Blood disorders
14.7.7.2.2.1.3.Renal disorders
14.7.7.2.2.1.4.Autoimmune disorders
14.7.7.2.2.1.5.Metabolic disorders
14.7.7.2.2.1.6.Cardiovascular disorders
14.7.7.2.2.1.7.Other disorders
14.7.7.2.2.2.Therapeutic apheresis devices
14.7.7.3.Benelux Union Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.7.3.1.Centrifugation
14.7.7.3.1.1.Continuous flow centrifugation
14.7.7.3.1.2.Intermittent flow centrifugation
14.7.7.3.2.Membrane separation
14.7.7.4.Benelux Union Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.4.1.Plasmapheresis
14.7.7.4.2.Plateletpheresis
14.7.7.4.3.Erythrocytapheresis
14.7.7.4.4.Leukapheresis
14.7.7.4.5.Photopheresis
14.7.7.4.6.Other applications
14.7.7.5.Benelux Union Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.7.5.1.Blood collection centers and blood component providers
14.7.7.5.2.Hospitals and transfusion centers
14.7.7.5.3.Other end users
14.7.7.6.Benelux Union Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1.Belgium
14.7.7.6.2.The Netherlands
14.7.7.6.3.Luxembourg
14.7.8.Rest of Europe
14.7.8.1.Rest of Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
14.7.8.1.1.Apheresis disposables
14.7.8.1.2.Apheresis devices
14.7.8.1.2.1.Centrifugal apheresis devices
14.7.8.1.2.2.Membrane separators
14.7.8.2.Rest of Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
14.7.8.2.1.Automated blood collection
14.7.8.2.2.Therapeutic apheresis
14.7.8.2.2.1.Therapeutic apheresis disposables
14.7.8.2.2.1.1.Neurological disorders
14.7.8.2.2.1.2.Blood disorders
14.7.8.2.2.1.3.Renal disorders
14.7.8.2.2.1.4.Autoimmune disorders
14.7.8.2.2.1.5.Metabolic disorders
14.7.8.2.2.1.6.Cardiovascular disorders
14.7.8.2.2.1.7.Other disorders
14.7.8.2.2.2.Therapeutic apheresis devices
14.7.8.3.Rest of Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.8.3.1.Centrifugation
14.7.8.3.1.1.Continuous flow centrifugation
14.7.8.3.1.2.Intermittent flow centrifugation
14.7.8.3.2.Membrane separation
14.7.8.4.Rest of Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.8.4.1.Plasmapheresis
14.7.8.4.2.Plateletpheresis
14.7.8.4.3.Erythrocytapheresis
14.7.8.4.4.Leukapheresis
14.7.8.4.5.Photopheresis
14.7.8.4.6.Other applications
14.7.8.5.Rest of Europe Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
14.7.8.5.1.Blood collection centers and blood component providers
14.7.8.5.2.Hospitals and transfusion centers
14.7.8.5.3.Other end users
14.8.Key Segment for Channeling Investments
14.8.1.By Country
14.8.2.By Product
14.8.3.By Procedure
14.8.4.By Technology
14.8.5.By Application
14.8.6.By End User
15.Asia Pacific Apheresis Market Analysis and Forecasts, 2024 – 2034
15.1.Overview
15.1.1.Asia Pacific Apheresis Market Revenue (US$ Mn)
15.2.Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.2.1.Apheresis disposables
15.2.2.Apheresis devices
15.2.2.1.Centrifugal apheresis devices
15.2.2.2.Membrane separators
15.3.Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.3.1.Automated blood collection
15.3.2.Therapeutic apheresis
15.3.2.1.Therapeutic apheresis disposables
15.3.2.1.1.Neurological disorders
15.3.2.1.2.Blood disorders
15.3.2.1.3.Renal disorders
15.3.2.1.4.Autoimmune disorders
15.3.2.1.5.Metabolic disorders
15.3.2.1.6.Cardiovascular disorders
15.3.2.1.7.Other disorders
15.3.2.2.Therapeutic apheresis devices
15.4.Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.4.1.Centrifugation
15.4.1.1.Continuous flow centrifugation
15.4.1.2.Intermittent flow centrifugation
15.4.2.Membrane separation
15.5.Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.Plasmapheresis
15.5.2.Plateletpheresis
15.5.3.Erythrocytapheresis
15.5.4.Leukapheresis
15.5.5.Photopheresis
15.5.6.Other applications
15.6.Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.6.1.Blood collection centers and blood component providers
15.6.2.Hospitals and transfusion centers
15.6.3.Other end users
15.7.Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1.China
15.7.1.1.China Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.1.1.1.Apheresis disposables
15.7.1.1.2.Apheresis devices
15.7.1.1.2.1.Centrifugal apheresis devices
15.7.1.1.2.2.Membrane separators
15.7.1.2.China Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.1.2.1.Automated blood collection
15.7.1.2.2.Therapeutic apheresis
15.7.1.2.2.1.Therapeutic apheresis disposables
15.7.1.2.2.1.1.Neurological disorders
15.7.1.2.2.1.2.Blood disorders
15.7.1.2.2.1.3.Renal disorders
15.7.1.2.2.1.4.Autoimmune disorders
15.7.1.2.2.1.5.Metabolic disorders
15.7.1.2.2.1.6.Cardiovascular disorders
15.7.1.2.2.1.7.Other disorders
15.7.1.2.2.2.Therapeutic apheresis devices
15.7.1.3.China Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.1.3.1.Centrifugation
15.7.1.3.1.1.Continuous flow centrifugation
15.7.1.3.1.2.Intermittent flow centrifugation
15.7.1.3.2.Membrane separation
15.7.1.4.China Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.4.1.Plasmapheresis
15.7.1.4.2.Plateletpheresis
15.7.1.4.3.Erythrocytapheresis
15.7.1.4.4.Leukapheresis
15.7.1.4.5.Photopheresis
15.7.1.4.6.Other applications
15.7.1.5.China Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.1.5.1.Blood collection centers and blood component providers
15.7.1.5.2.Hospitals and transfusion centers
15.7.1.5.3.Other end users
15.7.2.Japan
15.7.2.1.Japan Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.2.1.1.Apheresis disposables
15.7.2.1.2.Apheresis devices
15.7.2.1.2.1.Centrifugal apheresis devices
15.7.2.1.2.2.Membrane separators
15.7.2.2.Japan Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.2.2.1.Automated blood collection
15.7.2.2.2.Therapeutic apheresis
15.7.2.2.2.1.Therapeutic apheresis disposables
15.7.2.2.2.1.1.Neurological disorders
15.7.2.2.2.1.2.Blood disorders
15.7.2.2.2.1.3.Renal disorders
15.7.2.2.2.1.4.Autoimmune disorders
15.7.2.2.2.1.5.Metabolic disorders
15.7.2.2.2.1.6.Cardiovascular disorders
15.7.2.2.2.1.7.Other disorders
15.7.2.2.2.2.Therapeutic apheresis devices
15.7.2.3.Japan Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.2.3.1.Centrifugation
15.7.2.3.1.1.Continuous flow centrifugation
15.7.2.3.1.2.Intermittent flow centrifugation
15.7.2.3.2.Membrane separation
15.7.2.4.Japan Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.4.1.Plasmapheresis
15.7.2.4.2.Plateletpheresis
15.7.2.4.3.Erythrocytapheresis
15.7.2.4.4.Leukapheresis
15.7.2.4.5.Photopheresis
15.7.2.4.6.Other applications
15.7.2.5.Japan Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.2.5.1.Blood collection centers and blood component providers
15.7.2.5.2.Hospitals and transfusion centers
15.7.2.5.3.Other end users
15.7.3.India
15.7.3.1.India Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.3.1.1.Apheresis disposables
15.7.3.1.2.Apheresis devices
15.7.3.1.2.1.Centrifugal apheresis devices
15.7.3.1.2.2.Membrane separators
15.7.3.2.India Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.3.2.1.Automated blood collection
15.7.3.2.2.Therapeutic apheresis
15.7.3.2.2.1.Therapeutic apheresis disposables
15.7.3.2.2.1.1.Neurological disorders
15.7.3.2.2.1.2.Blood disorders
15.7.3.2.2.1.3.Renal disorders
15.7.3.2.2.1.4.Autoimmune disorders
15.7.3.2.2.1.5.Metabolic disorders
15.7.3.2.2.1.6.Cardiovascular disorders
15.7.3.2.2.1.7.Other disorders
15.7.3.2.2.2.Therapeutic apheresis devices
15.7.3.3.India Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.3.3.1.Centrifugation
15.7.3.3.1.1.Continuous flow centrifugation
15.7.3.3.1.2.Intermittent flow centrifugation
15.7.3.3.2.Membrane separation
15.7.3.4.India Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.4.1.Plasmapheresis
15.7.3.4.2.Plateletpheresis
15.7.3.4.3.Erythrocytapheresis
15.7.3.4.4.Leukapheresis
15.7.3.4.5.Photopheresis
15.7.3.4.6.Other applications
15.7.3.5.India Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.3.5.1.Blood collection centers and blood component providers
15.7.3.5.2.Hospitals and transfusion centers
15.7.3.5.3.Other end users
15.7.4.New Zealand
15.7.4.1.New Zealand Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.4.1.1.Apheresis disposables
15.7.4.1.2.Apheresis devices
15.7.4.1.2.1.Centrifugal apheresis devices
15.7.4.1.2.2.Membrane separators
15.7.4.2.New Zealand Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.4.2.1.Automated blood collection
15.7.4.2.2.Therapeutic apheresis
15.7.4.2.2.1.Therapeutic apheresis disposables
15.7.4.2.2.1.1.Neurological disorders
15.7.4.2.2.1.2.Blood disorders
15.7.4.2.2.1.3.Renal disorders
15.7.4.2.2.1.4.Autoimmune disorders
15.7.4.2.2.1.5.Metabolic disorders
15.7.4.2.2.1.6.Cardiovascular disorders
15.7.4.2.2.1.7.Other disorders
15.7.4.2.2.2.Therapeutic apheresis devices
15.7.4.3.New Zealand Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.4.3.1.Centrifugation
15.7.4.3.1.1.Continuous flow centrifugation
15.7.4.3.1.2.Intermittent flow centrifugation
15.7.4.3.2.Membrane separation
15.7.4.4.New Zealand Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.4.4.1.Plasmapheresis
15.7.4.4.2.Plateletpheresis
15.7.4.4.3.Erythrocytapheresis
15.7.4.4.4.Leukapheresis
15.7.4.4.5.Photopheresis
15.7.4.4.6.Other applications
15.7.4.5.New Zealand Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.4.5.1.Blood collection centers and blood component providers
15.7.4.5.2.Hospitals and transfusion centers
15.7.4.5.3.Other end users
15.7.5.Australia
15.7.5.1.Australia Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.5.1.1.Apheresis disposables
15.7.5.1.2.Apheresis devices
15.7.5.1.2.1.Centrifugal apheresis devices
15.7.5.1.2.2.Membrane separators
15.7.5.2.Australia Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.5.2.1.Automated blood collection
15.7.5.2.2.Therapeutic apheresis
15.7.5.2.2.1.Therapeutic apheresis disposables
15.7.5.2.2.1.1.Neurological disorders
15.7.5.2.2.1.2.Blood disorders
15.7.5.2.2.1.3.Renal disorders
15.7.5.2.2.1.4.Autoimmune disorders
15.7.5.2.2.1.5.Metabolic disorders
15.7.5.2.2.1.6.Cardiovascular disorders
15.7.5.2.2.1.7.Other disorders
15.7.5.2.2.2.Therapeutic apheresis devices
15.7.5.3.Australia Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.5.3.1.Centrifugation
15.7.5.3.1.1.Continuous flow centrifugation
15.7.5.3.1.2.Intermittent flow centrifugation
15.7.5.3.2.Membrane separation
15.7.5.4.Australia Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.4.1.Plasmapheresis
15.7.5.4.2.Plateletpheresis
15.7.5.4.3.Erythrocytapheresis
15.7.5.4.4.Leukapheresis
15.7.5.4.5.Photopheresis
15.7.5.4.6.Other applications
15.7.5.5.Australia Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.5.5.1.Blood collection centers and blood component providers
15.7.5.5.2.Hospitals and transfusion centers
15.7.5.5.3.Other end users
15.7.6.South Korea
15.7.6.1.South Korea Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.6.1.1.Apheresis disposables
15.7.6.1.2.Apheresis devices
15.7.6.1.2.1.Centrifugal apheresis devices
15.7.6.1.2.2.Membrane separators
15.7.6.2.South Korea Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.6.2.1.Automated blood collection
15.7.6.2.2.Therapeutic apheresis
15.7.6.2.2.1.Therapeutic apheresis disposables
15.7.6.2.2.1.1.Neurological disorders
15.7.6.2.2.1.2.Blood disorders
15.7.6.2.2.1.3.Renal disorders
15.7.6.2.2.1.4.Autoimmune disorders
15.7.6.2.2.1.5.Metabolic disorders
15.7.6.2.2.1.6.Cardiovascular disorders
15.7.6.2.2.1.7.Other disorders
15.7.6.2.2.2.Therapeutic apheresis devices
15.7.6.3.South Korea Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.6.3.1.Centrifugation
15.7.6.3.1.1.Continuous flow centrifugation
15.7.6.3.1.2.Intermittent flow centrifugation
15.7.6.3.2.Membrane separation
15.7.6.4.South Korea Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.4.1.Plasmapheresis
15.7.6.4.2.Plateletpheresis
15.7.6.4.3.Erythrocytapheresis
15.7.6.4.4.Leukapheresis
15.7.6.4.5.Photopheresis
15.7.6.4.6.Other applications
15.7.6.5.South Korea Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.6.5.1.Blood collection centers and blood component providers
15.7.6.5.2.Hospitals and transfusion centers
15.7.6.5.3.Other end users
15.7.7.Southeast Asia
15.7.7.1.Southeast Asia Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.7.1.1.Apheresis disposables
15.7.7.1.2.Apheresis devices
15.7.7.1.2.1.Centrifugal apheresis devices
15.7.7.1.2.2.Membrane separators
15.7.7.2.Southeast Asia Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.7.2.1.Automated blood collection
15.7.7.2.2.Therapeutic apheresis
15.7.7.2.2.1.Therapeutic apheresis disposables
15.7.7.2.2.1.1.Neurological disorders
15.7.7.2.2.1.2.Blood disorders
15.7.7.2.2.1.3.Renal disorders
15.7.7.2.2.1.4.Autoimmune disorders
15.7.7.2.2.1.5.Metabolic disorders
15.7.7.2.2.1.6.Cardiovascular disorders
15.7.7.2.2.1.7.Other disorders
15.7.7.2.2.2.Therapeutic apheresis devices
15.7.7.3.Southeast Asia Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.7.3.1.Centrifugation
15.7.7.3.1.1.Continuous flow centrifugation
15.7.7.3.1.2.Intermittent flow centrifugation
15.7.7.3.2.Membrane separation
15.7.7.4.Southeast Asia Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.4.1.Plasmapheresis
15.7.7.4.2.Plateletpheresis
15.7.7.4.3.Erythrocytapheresis
15.7.7.4.4.Leukapheresis
15.7.7.4.5.Photopheresis
15.7.7.4.6.Other applications
15.7.7.5.Southeast Asia Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.7.5.1.Blood collection centers and blood component providers
15.7.7.5.2.Hospitals and transfusion centers
15.7.7.5.3.Other end users
15.7.7.6.Southeast Asia Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1.Indonesia
15.7.7.6.2.Thailand
15.7.7.6.3.Malaysia
15.7.7.6.4.Singapore
15.7.7.6.5.Rest of Southeast Asia
15.7.8.Rest of Asia Pacific
15.7.8.1.Rest of Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
15.7.8.1.1.Apheresis disposables
15.7.8.1.2.Apheresis devices
15.7.8.1.2.1.Centrifugal apheresis devices
15.7.8.1.2.2.Membrane separators
15.7.8.2.Rest of Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
15.7.8.2.1.Automated blood collection
15.7.8.2.2.Therapeutic apheresis
15.7.8.2.2.1.Therapeutic apheresis disposables
15.7.8.2.2.1.1.Neurological disorders
15.7.8.2.2.1.2.Blood disorders
15.7.8.2.2.1.3.Renal disorders
15.7.8.2.2.1.4.Autoimmune disorders
15.7.8.2.2.1.5.Metabolic disorders
15.7.8.2.2.1.6.Cardiovascular disorders
15.7.8.2.2.1.7.Other disorders
15.7.8.2.2.2.Therapeutic apheresis devices
15.7.8.3.Rest of Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.8.3.1.Centrifugation
15.7.8.3.1.1.Continuous flow centrifugation
15.7.8.3.1.2.Intermittent flow centrifugation
15.7.8.3.2.Membrane separation
15.7.8.4.Rest of Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.8.4.1.Plasmapheresis
15.7.8.4.2.Plateletpheresis
15.7.8.4.3.Erythrocytapheresis
15.7.8.4.4.Leukapheresis
15.7.8.4.5.Photopheresis
15.7.8.4.6.Other applications
15.7.8.5.Rest of Asia Pacific Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
15.7.8.5.1.Blood collection centers and blood component providers
15.7.8.5.2.Hospitals and transfusion centers
15.7.8.5.3.Other end users
15.8.Key Segment for Channeling Investments
15.8.1.By Country
15.8.2.By Product
15.8.3.By Procedure
15.8.4.By Technology
15.8.5.By Application
15.8.6.By End User
16.Middle East and Africa Apheresis Market Analysis and Forecasts, 2024 – 2034
16.1.Overview
16.1.1.Middle East and Africa Apheresis Market Revenue (US$ Mn)
16.2.Middle East and Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.2.1.Apheresis disposables
16.2.2.Apheresis devices
16.2.2.1.Centrifugal apheresis devices
16.2.2.2.Membrane separators
16.3.Middle East and Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.3.1.Automated blood collection
16.3.2.Therapeutic apheresis
16.3.2.1.Therapeutic apheresis disposables
16.3.2.1.1.Neurological disorders
16.3.2.1.2.Blood disorders
16.3.2.1.3.Renal disorders
16.3.2.1.4.Autoimmune disorders
16.3.2.1.5.Metabolic disorders
16.3.2.1.6.Cardiovascular disorders
16.3.2.1.7.Other disorders
16.3.2.2.Therapeutic apheresis devices
16.4.Middle East and Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.4.1.Centrifugation
16.4.1.1.Continuous flow centrifugation
16.4.1.2.Intermittent flow centrifugation
16.4.2.Membrane separation
16.5.Middle East and Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.5.1.Plasmapheresis
16.5.2.Plateletpheresis
16.5.3.Erythrocytapheresis
16.5.4.Leukapheresis
16.5.5.Photopheresis
16.5.6.Other applications
16.6.Middle East and Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.6.1.Blood collection centers and blood component providers
16.6.2.Hospitals and transfusion centers
16.6.3.Other end users
16.7.Middle East and Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1.Saudi Arabia
16.7.1.1.Saudi Arabia Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.7.1.1.1.Apheresis disposables
16.7.1.1.2.Apheresis devices
16.7.1.1.2.1.Centrifugal apheresis devices
16.7.1.1.2.2.Membrane separators
16.7.1.2.Saudi Arabia Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.7.1.2.1.Automated blood collection
16.7.1.2.2.Therapeutic apheresis
16.7.1.2.2.1.Therapeutic apheresis disposables
16.7.1.2.2.1.1.Neurological disorders
16.7.1.2.2.1.2.Blood disorders
16.7.1.2.2.1.3.Renal disorders
16.7.1.2.2.1.4.Autoimmune disorders
16.7.1.2.2.1.5.Metabolic disorders
16.7.1.2.2.1.6.Cardiovascular disorders
16.7.1.2.2.1.7.Other disorders
16.7.1.2.2.2.Therapeutic apheresis devices
16.7.1.3.Saudi Arabia Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.1.3.1.Centrifugation
16.7.1.3.1.1.Continuous flow centrifugation
16.7.1.3.1.2.Intermittent flow centrifugation
16.7.1.3.2.Membrane separation
16.7.1.4.Saudi Arabia Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.4.1.Plasmapheresis
16.7.1.4.2.Plateletpheresis
16.7.1.4.3.Erythrocytapheresis
16.7.1.4.4.Leukapheresis
16.7.1.4.5.Photopheresis
16.7.1.4.6.Other applications
16.7.1.5.Saudi Arabia Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.7.1.5.1.Blood collection centers and blood component providers
16.7.1.5.2.Hospitals and transfusion centers
16.7.1.5.3.Other end users
16.7.2.UAE
16.7.2.1.UAE Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.7.2.1.1.Apheresis disposables
16.7.2.1.2.Apheresis devices
16.7.2.1.2.1.Centrifugal apheresis devices
16.7.2.1.2.2.Membrane separators
16.7.2.2.UAE Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.7.2.2.1.Automated blood collection
16.7.2.2.2.Therapeutic apheresis
16.7.2.2.2.1.Therapeutic apheresis disposables
16.7.2.2.2.1.1.Neurological disorders
16.7.2.2.2.1.2.Blood disorders
16.7.2.2.2.1.3.Renal disorders
16.7.2.2.2.1.4.Autoimmune disorders
16.7.2.2.2.1.5.Metabolic disorders
16.7.2.2.2.1.6.Cardiovascular disorders
16.7.2.2.2.1.7.Other disorders
16.7.2.2.2.2.Therapeutic apheresis devices
16.7.2.3.UAE Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.2.3.1.Centrifugation
16.7.2.3.1.1.Continuous flow centrifugation
16.7.2.3.1.2.Intermittent flow centrifugation
16.7.2.3.2.Membrane separation
16.7.2.4.UAE Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.4.1.Plasmapheresis
16.7.2.4.2.Plateletpheresis
16.7.2.4.3.Erythrocytapheresis
16.7.2.4.4.Leukapheresis
16.7.2.4.5.Photopheresis
16.7.2.4.6.Other applications
16.7.2.5.UAE Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.7.2.5.1.Blood collection centers and blood component providers
16.7.2.5.2.Hospitals and transfusion centers
16.7.2.5.3.Other end users
16.7.3.Egypt
16.7.3.1.Egypt Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.7.3.1.1.Apheresis disposables
16.7.3.1.2.Apheresis devices
16.7.3.1.2.1.Centrifugal apheresis devices
16.7.3.1.2.2.Membrane separators
16.7.3.2.Egypt Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.7.3.2.1.Automated blood collection
16.7.3.2.2.Therapeutic apheresis
16.7.3.2.2.1.Therapeutic apheresis disposables
16.7.3.2.2.1.1.Neurological disorders
16.7.3.2.2.1.2.Blood disorders
16.7.3.2.2.1.3.Renal disorders
16.7.3.2.2.1.4.Autoimmune disorders
16.7.3.2.2.1.5.Metabolic disorders
16.7.3.2.2.1.6.Cardiovascular disorders
16.7.3.2.2.1.7.Other disorders
16.7.3.2.2.2.Therapeutic apheresis devices
16.7.3.3.Egypt Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.3.3.1.Centrifugation
16.7.3.3.1.1.Continuous flow centrifugation
16.7.3.3.1.2.Intermittent flow centrifugation
16.7.3.3.2.Membrane separation
16.7.3.4.Egypt Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.4.1.Plasmapheresis
16.7.3.4.2.Plateletpheresis
16.7.3.4.3.Erythrocytapheresis
16.7.3.4.4.Leukapheresis
16.7.3.4.5.Photopheresis
16.7.3.4.6.Other applications
16.7.3.5.Egypt Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.7.3.5.1.Blood collection centers and blood component providers
16.7.3.5.2.Hospitals and transfusion centers
16.7.3.5.3.Other end users
16.7.4.Kuwait
16.7.4.1.Kuwait Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.7.4.1.1.Apheresis disposables
16.7.4.1.2.Apheresis devices
16.7.4.1.2.1.Centrifugal apheresis devices
16.7.4.1.2.2.Membrane separators
16.7.4.2.Kuwait Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.7.4.2.1.Automated blood collection
16.7.4.2.2.Therapeutic apheresis
16.7.4.2.2.1.Therapeutic apheresis disposables
16.7.4.2.2.1.1.Neurological disorders
16.7.4.2.2.1.2.Blood disorders
16.7.4.2.2.1.3.Renal disorders
16.7.4.2.2.1.4.Autoimmune disorders
16.7.4.2.2.1.5.Metabolic disorders
16.7.4.2.2.1.6.Cardiovascular disorders
16.7.4.2.2.1.7.Other disorders
16.7.4.2.2.2.Therapeutic apheresis devices
16.7.4.3.Kuwait Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.4.3.1.Centrifugation
16.7.4.3.1.1.Continuous flow centrifugation
16.7.4.3.1.2.Intermittent flow centrifugation
16.7.4.3.2.Membrane separation
16.7.4.4.Kuwait Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.4.1.Plasmapheresis
16.7.4.4.2.Plateletpheresis
16.7.4.4.3.Erythrocytapheresis
16.7.4.4.4.Leukapheresis
16.7.4.4.5.Photopheresis
16.7.4.4.6.Other applications
16.7.4.5.Kuwait Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.7.4.5.1.Blood collection centers and blood component providers
16.7.4.5.2.Hospitals and transfusion centers
16.7.4.5.3.Other end users
16.7.5.South Africa
16.7.5.1.South Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.7.5.1.1.Apheresis disposables
16.7.5.1.2.Apheresis devices
16.7.5.1.2.1.Centrifugal apheresis devices
16.7.5.1.2.2.Membrane separators
16.7.5.2.South Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.7.5.2.1.Automated blood collection
16.7.5.2.2.Therapeutic apheresis
16.7.5.2.2.1.Therapeutic apheresis disposables
16.7.5.2.2.1.1.Neurological disorders
16.7.5.2.2.1.2.Blood disorders
16.7.5.2.2.1.3.Renal disorders
16.7.5.2.2.1.4.Autoimmune disorders
16.7.5.2.2.1.5.Metabolic disorders
16.7.5.2.2.1.6.Cardiovascular disorders
16.7.5.2.2.1.7.Other disorders
16.7.5.2.2.2.Therapeutic apheresis devices
16.7.5.3.South Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.5.3.1.Centrifugation
16.7.5.3.1.1.Continuous flow centrifugation
16.7.5.3.1.2.Intermittent flow centrifugation
16.7.5.3.2.Membrane separation
16.7.5.4.South Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.4.1.Plasmapheresis
16.7.5.4.2.Plateletpheresis
16.7.5.4.3.Erythrocytapheresis
16.7.5.4.4.Leukapheresis
16.7.5.4.5.Photopheresis
16.7.5.4.6.Other applications
16.7.5.5.South Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.7.5.5.1.Blood collection centers and blood component providers
16.7.5.5.2.Hospitals and transfusion centers
16.7.5.5.3.Other end users
16.7.6.Rest of Middle East & Africa
16.7.6.1.Rest of Middle East & Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
16.7.6.1.1.Apheresis disposables
16.7.6.1.2.Apheresis devices
16.7.6.1.2.1.Centrifugal apheresis devices
16.7.6.1.2.2.Membrane separators
16.7.6.2.Rest of Middle East & Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
16.7.6.2.1.Automated blood collection
16.7.6.2.2.Therapeutic apheresis
16.7.6.2.2.1.Therapeutic apheresis disposables
16.7.6.2.2.1.1.Neurological disorders
16.7.6.2.2.1.2.Blood disorders
16.7.6.2.2.1.3.Renal disorders
16.7.6.2.2.1.4.Autoimmune disorders
16.7.6.2.2.1.5.Metabolic disorders
16.7.6.2.2.1.6.Cardiovascular disorders
16.7.6.2.2.1.7.Other disorders
16.7.6.2.2.2.Therapeutic apheresis devices
16.7.6.3.Rest of Middle East & Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.6.3.1.Centrifugation
16.7.6.3.1.1.Continuous flow centrifugation
16.7.6.3.1.2.Intermittent flow centrifugation
16.7.6.3.2.Membrane separation
16.7.6.4.Rest of Middle East & Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.6.4.1.Plasmapheresis
16.7.6.4.2.Plateletpheresis
16.7.6.4.3.Erythrocytapheresis
16.7.6.4.4.Leukapheresis
16.7.6.4.5.Photopheresis
16.7.6.4.6.Other applications
16.7.6.5.Rest of Middle East & Africa Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
16.7.6.5.1.Blood collection centers and blood component providers
16.7.6.5.2.Hospitals and transfusion centers
16.7.6.5.3.Other end users
16.8.Key Segment for Channeling Investments
16.8.1.By Country
16.8.2.By Product
16.8.3.By Procedure
16.8.4.By Technology
16.8.5.By Application
16.8.6.By End User
17.Latin America Apheresis Market Analysis and Forecasts, 2024 – 2034
17.1.Overview
17.1.1.Latin America Apheresis Market Revenue (US$ Mn)
17.2.Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
17.2.1.Apheresis disposables
17.2.2.Apheresis devices
17.2.2.1.Centrifugal apheresis devices
17.2.2.2.Membrane separators
17.3.Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
17.3.1.Automated blood collection
17.3.2.Therapeutic apheresis
17.3.2.1.Therapeutic apheresis disposables
17.3.2.1.1.Neurological disorders
17.3.2.1.2.Blood disorders
17.3.2.1.3.Renal disorders
17.3.2.1.4.Autoimmune disorders
17.3.2.1.5.Metabolic disorders
17.3.2.1.6.Cardiovascular disorders
17.3.2.1.7.Other disorders
17.3.2.2.Therapeutic apheresis devices
17.4.Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
17.4.1.Centrifugation
17.4.1.1.Continuous flow centrifugation
17.4.1.2.Intermittent flow centrifugation
17.4.2.Membrane separation
17.5.Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
17.5.1.Plasmapheresis
17.5.2.Plateletpheresis
17.5.3.Erythrocytapheresis
17.5.4.Leukapheresis
17.5.5.Photopheresis
17.5.6.Other applications
17.6.Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
17.6.1.Blood collection centers and blood component providers
17.6.2.Hospitals and transfusion centers
17.6.3.Other end users
17.7.Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1.Brazil
17.7.1.1.Brazil Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
17.7.1.1.1.Apheresis disposables
17.7.1.1.2.Apheresis devices
17.7.1.1.2.1.Centrifugal apheresis devices
17.7.1.1.2.2.Membrane separators
17.7.1.2.Brazil Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
17.7.1.2.1.Automated blood collection
17.7.1.2.2.Therapeutic apheresis
17.7.1.2.2.1.Therapeutic apheresis disposables
17.7.1.2.2.1.1.Neurological disorders
17.7.1.2.2.1.2.Blood disorders
17.7.1.2.2.1.3.Renal disorders
17.7.1.2.2.1.4.Autoimmune disorders
17.7.1.2.2.1.5.Metabolic disorders
17.7.1.2.2.1.6.Cardiovascular disorders
17.7.1.2.2.1.7.Other disorders
17.7.1.2.2.2.Therapeutic apheresis devices
17.7.1.3.Brazil Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.1.3.1.Centrifugation
17.7.1.3.1.1.Continuous flow centrifugation
17.7.1.3.1.2.Intermittent flow centrifugation
17.7.1.3.2.Membrane separation
17.7.1.4.Brazil Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.4.1.Plasmapheresis
17.7.1.4.2.Plateletpheresis
17.7.1.4.3.Erythrocytapheresis
17.7.1.4.4.Leukapheresis
17.7.1.4.5.Photopheresis
17.7.1.4.6.Other applications
17.7.1.5.Brazil Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
17.7.1.5.1.Blood collection centers and blood component providers
17.7.1.5.2.Hospitals and transfusion centers
17.7.1.5.3.Other end users
17.7.2.Argentina
17.7.2.1.Argentina Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
17.7.2.1.1.Apheresis disposables
17.7.2.1.2.Apheresis devices
17.7.2.1.2.1.Centrifugal apheresis devices
17.7.2.1.2.2.Membrane separators
17.7.2.2.Argentina Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
17.7.2.2.1.Automated blood collection
17.7.2.2.2.Therapeutic apheresis
17.7.2.2.2.1.Therapeutic apheresis disposables
17.7.2.2.2.1.1.Neurological disorders
17.7.2.2.2.1.2.Blood disorders
17.7.2.2.2.1.3.Renal disorders
17.7.2.2.2.1.4.Autoimmune disorders
17.7.2.2.2.1.5.Metabolic disorders
17.7.2.2.2.1.6.Cardiovascular disorders
17.7.2.2.2.1.7.Other disorders
17.7.2.2.2.2.Therapeutic apheresis devices
17.7.2.3.Argentina Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.2.3.1.Centrifugation
17.7.2.3.1.1.Continuous flow centrifugation
17.7.2.3.1.2.Intermittent flow centrifugation
17.7.2.3.2.Membrane separation
17.7.2.4.Argentina Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.4.1.Plasmapheresis
17.7.2.4.2.Plateletpheresis
17.7.2.4.3.Erythrocytapheresis
17.7.2.4.4.Leukapheresis
17.7.2.4.5.Photopheresis
17.7.2.4.6.Other applications
17.7.2.5.Argentina Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
17.7.2.5.1.Blood collection centers and blood component providers
17.7.2.5.2.Hospitals and transfusion centers
17.7.2.5.3.Other end users
17.7.3.Rest of Latin America
17.7.3.1.Rest of Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Product
17.7.3.1.1.Apheresis disposables
17.7.3.1.2.Apheresis devices
17.7.3.1.2.1.Centrifugal apheresis devices
17.7.3.1.2.2.Membrane separators
17.7.3.2.Rest of Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Procedure
17.7.3.2.1.Automated blood collection
17.7.3.2.2.Therapeutic apheresis
17.7.3.2.2.1.Therapeutic apheresis disposables
17.7.3.2.2.1.1.Neurological disorders
17.7.3.2.2.1.2.Blood disorders
17.7.3.2.2.1.3.Renal disorders
17.7.3.2.2.1.4.Autoimmune disorders
17.7.3.2.2.1.5.Metabolic disorders
17.7.3.2.2.1.6.Cardiovascular disorders
17.7.3.2.2.1.7.Other disorders
17.7.3.2.2.2.Therapeutic apheresis devices
17.7.3.3.Rest of Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.3.3.1.Centrifugation
17.7.3.3.1.1.Continuous flow centrifugation
17.7.3.3.1.2.Intermittent flow centrifugation
17.7.3.3.2.Membrane separation
17.7.3.4.Rest of Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By Application
17.7.3.4.1.Plasmapheresis
17.7.3.4.2.Plateletpheresis
17.7.3.4.3.Erythrocytapheresis
17.7.3.4.4.Leukapheresis
17.7.3.4.5.Photopheresis
17.7.3.4.6.Other applications
17.7.3.5.Rest of Latin America Apheresis Market Revenue (US$ Mn) and Forecasts, By End User
17.7.3.5.1.Blood collection centers and blood component providers
17.7.3.5.2.Hospitals and transfusion centers
17.7.3.5.3.Other end users
17.8.Key Segment for Channeling Investments
17.8.1.By Country
17.8.2.By Product
17.8.3.By Procedure
17.8.4.By Technology
17.8.5.By Application
17.8.6.By End User
18.Competitive Benchmarking
18.1.Brand Benchmarking
18.2.Market Share Analysis, 2023
18.3.Global Presence and Growth Strategies
18.3.1.Mergers and Acquisitions
18.3.2.Product Launches
18.3.3.Investments Trends
18.3.4.R&D Initiatives
19.Player Profiles
19.1.Asahi Kasei Medical Co. Ltd.
19.1.1.Company Details
19.1.2.Company Overview
19.1.3.Product Offerings
19.1.4.Key Developments
19.1.5.Financial Analysis
19.1.6.SWOT Analysis
19.1.7.Business Strategies
19.2.Baxter International
19.2.1.Company Details
19.2.2.Company Overview
19.2.3.Product Offerings
19.2.4.Key Developments
19.2.5.Financial Analysis
19.2.6.SWOT Analysis
19.2.7.Business Strategies
19.3.Cerus Corporation
19.3.1.Company Details
19.3.2.Company Overview
19.3.3.Product Offerings
19.3.4.Key Developments
19.3.5.Financial Analysis
19.3.6.SWOT Analysis
19.3.7.Business Strategies
19.4.Fresenius Medical Care
19.4.1.Company Details
19.4.2.Company Overview
19.4.3.Product Offerings
19.4.4.Key Developments
19.4.5.Financial Analysis
19.4.6.SWOT Analysis
19.4.7.Business Strategies
19.5.Haemonetics Corporation
19.5.1.Company Details
19.5.2.Company Overview
19.5.3.Product Offerings
19.5.4.Key Developments
19.5.5.Financial Analysis
19.5.6.SWOT Analysis
19.5.7.Business Strategies
19.6.HemaCare Corporation
19.6.1.Company Details
19.6.2.Company Overview
19.6.3.Product Offerings
19.6.4.Key Developments
19.6.5.Financial Analysis
19.6.6.SWOT Analysis
19.6.7.Business Strategies
19.7.Kaneka Corporation
19.7.1.Company Details
19.7.2.Company Overview
19.7.3.Product Offerings
19.7.4.Key Developments
19.7.5.Financial Analysis
19.7.6.SWOT Analysis
19.7.7.Business Strategies
19.8.Kawasumi Laboratories Inc.
19.8.1.Company Details
19.8.2.Company Overview
19.8.3.Product Offerings
19.8.4.Key Developments
19.8.5.Financial Analysis
19.8.6.SWOT Analysis
19.8.7.Business Strategies
19.9.Macopharma SA
19.9.1.Company Details
19.9.2.Company Overview
19.9.3.Product Offerings
19.9.4.Key Developments
19.9.5.Financial Analysis
19.9.6.SWOT Analysis
19.9.7.Business Strategies
19.10.Nikkiso Co.Ltd.
19.10.1.Company Details
19.10.2.Company Overview
19.10.3.Product Offerings
19.10.4.Key Developments
19.10.5.Financial Analysis
19.10.6.SWOT Analysis
19.10.7.Business Strategies
19.11.Otsuka Holdings Co. Ltd
19.11.1.Company Details
19.11.2.Company Overview
19.11.3.Product Offerings
19.11.4.Key Developments
19.11.5.Financial Analysis
19.11.6.SWOT Analysis
19.11.7.Business Strategies
19.12.Terumo BCT Inc.
19.12.1.Company Details
19.12.2.Company Overview
19.12.3.Product Offerings
19.12.4.Key Developments
19.12.5.Financial Analysis
19.12.6.SWOT Analysis
19.12.7.Business Strategies
19.13.Other Industry Participants
20.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

Global Apheresis Market

By Product

  • Apheresis disposables
  • Apheresis devices
    • Centrifugal apheresis devices
    • Membrane separators

By Procedure

  • Automated blood collection
  • Therapeutic apheresis
    • Therapeutic apheresis disposables
      • Neurological disorders
      • Blood disorders
      • Renal disorders
      • Autoimmune disorders
      • Metabolic disorders
      • Cardiovascular disorders
      • Other disorders
    • Therapeutic apheresis devices

By Technology

  • Centrifugation
    • Continuous flow centrifugation
    • Intermittent flow centrifugation
  • Membrane separation

By Application

  • Plasmapheresis
  • plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Photopheresis
  • Other applications

By End User

  • Blood collection centers and blood component providers
  • Hospitals and transfusion centers
  • Other end users

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Apheresis Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top